DNA methylation
DNMT and TET systems, methylation state, hydroxymethylation, repair-linked regulation, and identity persistence.
Epigenetic & Histone Intelligence
Epigenetics and histone biology across the BioAtlas estate.
BioAtlas maps epigenetics and histone biology as cross-estate intelligence rather than one isolated registry. DNA methylation, histone modification, chromatin architecture, regulatory RNA, enzyme behaviour, cell-state control, oncology hallmarks, pathway context, nutrigenetics, and multiomics interpretation all connect through this layer.
98
public-safe epigenetic target entries
1,679
DNA / methylation source files
2,493
histone source files
1,223
chromatin source files
4,371
regulatory RNA source files
Source-backed target layer
The public page treats the 98 target entries as a canonical public-safe epigenetic target layer, not the full estate size. Epigenetic and histone biology also run across wider BioAtlas datasets, enzymes, miRNA intelligence, chromatin systems, hallmarks, oncology mappings, pathways, nutrigenetics, and multiomics context.
+
Source-backed target layer
The public page treats the 98 target entries as a canonical public-safe epigenetic target layer, not the full estate size. Epigenetic and histone biology also run across wider BioAtlas datasets, enzymes, miRNA intelligence, chromatin systems, hallmarks, oncology mappings, pathways, nutrigenetics, and multiomics context.
Histone modification
Acetylation, deacetylation, methylation, demethylation, chromatin accessibility, and transcriptional control.
Chromatin remodelling
SWI/SNF, BAF, CHD, INO80 and related remodelling systems that influence accessibility and cellular identity.
Non-coding RNA
miRNA, siRNA, lncRNA and regulatory-RNA mechanisms linked to epigenetic control and systems adaptation.
Cross-estate bridges
BioAtlas contains enzyme-to-epigenetic bridge architecture and wider cross-estate references across histones, chromatin remodelling, DNA methylation, hallmark intelligence, pathway context, nutrigenetics, miRNA, multiomics, and systems-state interpretation.
+
Cross-estate bridges
BioAtlas contains enzyme-to-epigenetic bridge architecture and wider cross-estate references across histones, chromatin remodelling, DNA methylation, hallmark intelligence, pathway context, nutrigenetics, miRNA, multiomics, and systems-state interpretation.
Enzyme bridges
DNMT, TET, HDAC, HAT, HMT, HDM, PRMT and methyltransferase systems connect epigenetic state to enzyme intelligence.
miRNA and regulatory RNA
miRNA, lncRNA and non-coding RNA records connect epigenetic regulation to post-transcriptional control and oncology state change.
Hallmark and oncology mappings
Epigenetic reprogramming and non-mutational genome plasticity connect to cancer hallmarks, subtype mappings, IDH/ATRX-style contexts and lineage-state adaptation.
Pathway and nutrigenetic context
Methylation, chromatin, histone and regulatory RNA signals connect into pathway intelligence, nutrigenetic targets and multiomics interpretation.
Multiomics integration
Epigenetics sits alongside miRNA, pathways, proteins, biomarkers, metabolics, cells, microbiome context, and illness intelligence within the wider Multiomics estate.
+
Multiomics integration
Epigenetics sits alongside miRNA, pathways, proteins, biomarkers, metabolics, cells, microbiome context, and illness intelligence within the wider Multiomics estate.
Public proof, protected platform
The platform can be evaluated publicly without exposing the protected estate.
The public platform page explains the estate, engine families, proof layer, and access pathway. Deeper technical assets, app surfaces, raw datasets, and controlled demos remain protected until review.
Public layer
What can be seen publicly
public page summaries
route map and estate map
DOI and preprint links
research collection names
safe paper summaries
licence family names
buyer lane overview
safety and non-claims boundary
access request funnel
Protected layer
What requires review
protected manuscripts
private vault assets
raw datasets and data-room extracts
buyer packs and valuation notes
pricing and commercial terms
technical architecture detail
internal app surfaces
controlled demos
AI-use or derivative-use rights
Public visibility is not a licence. Public pages do not grant access to protected material, commercial terms, AI ingestion, derivative databases, model training, redistribution, replication, or clinical use.
Reviewed access
Protected epigenetic datasets, graph traversal, evidence layers, bridge systems, AI-use rights, exports, and commercial packaging remain behind reviewed BioAtlas access.
+
Reviewed access
Protected epigenetic datasets, graph traversal, evidence layers, bridge systems, AI-use rights, exports, and commercial packaging remain behind reviewed BioAtlas access.